{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-009667","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.848092+00:00","generated_at":"2026-05-21T23:12:18.336256+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Stereotaxis Q1 revenue $7.5M (+9% YoY); recurring up 29%; operating loss widens to $5.9M","bullets":["Revenue $7.5M (+9% YoY); system revenue $2.0M, recurring revenue $5.5M (+29% driven by Map-iT catheters).","Operating loss ($5.9M) vs ($4.7M) prior year; net loss ($5.8M) vs ($4.5M). Adjusted operating loss ($2.7M).","Cash $10.7M, no debt; free cash flow negative ($1.8M), improved from ($2.3M) YoY.","Reiterates FY 2025 double-digit revenue growth; expects recurring revenue to scale to $7M in Q4.","First GenesisX order received; initial MAGiC commercialization in Europe; six active regulatory reviews."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-009667","json":"https://secwatch.observer/filing/0001641172-25-009667.json","markdown":"https://secwatch.observer/filing/0001641172-25-009667.md","text":"https://secwatch.observer/filing/0001641172-25-009667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/0001641172-25-009667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T23:12:18.336256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}